title: Detection of infectious organisms in archival prostate cancer tissues.
abstract: BACKGROUND
  Seroepidemiological studies have reported associations between exposure to sexually transmitted organisms and prostate cancer risk. This study sought DNA evidence of candidate organisms in archival prostate cancer tissues with the aim of assessing if a subset of these cancers show any association with common genital infections.
  
  
  METHODS
  221 archival paraffin-embedded tissue blocks representing 128 histopathologically confirmed prostate cancers comprising 52 "aggressive" (Gleason score ≥ 7) and 76 "non-aggressive" (Gleason score ≤ 6) TURP or radical prostatectomy specimens were examined, as well as unaffected adjacent tissue when available. Representative tissue sections were subjected to DNA extraction, quality tested and screened by PCR for HSV-1, HSV-2, XMRV, BKV, HPV, Chlamydia trachomatis, Ureaplasma parvum, Ureaplasma urealyticum, Mycoplasma genitalium, and Trichomonas vaginalis.
  
  
  RESULTS
  195 of 221 DNA samples representing 49 "aggressive" and 66 "non-aggressive" prostate cancer cases were suitable for analysis after DNA quality assessment. Overall, 12.2% (6/49) aggressive and 7.6% (5/66) non-aggressive cases were positive for any of the candidate organisms. Mycoplasma genitalium DNA was detected in 4/66 non-aggressive, 5/49 aggressive cancers and in one cancer-unaffected adjacent tissue block of an aggressive case. Ureaplasma urealyticum DNA was detected in 0/66 non-aggressive and 1/49 aggressive cancers and HSV DNA in 1/66 non-aggressive and 0/49 aggressive cancers. This study did not detect BKV, XMRV, T. vaginalis, U. parvum, C. trachomatis or HPV DNA.
  
  
  CONCLUSIONS
  The low prevalence of detectable microbial DNA makes it unlikely that persistent infection by the selected candidate microorganisms contribute to prostate cancer risk, regardless of tumour phenotype.
authors.forename: Melissa A
authors.initials: MA
authors.lastname: Yow
authors.forename: Sepehr N
authors.initials: SN
authors.lastname: Tabrizi
authors.forename: Gianluca
authors.initials: G
authors.lastname: Severi
authors.forename: Damien M
authors.initials: DM
authors.lastname: Bolton
authors.forename: John
authors.initials: J
authors.lastname: Pedersen
authors.forename: Anthony
authors.initials: A
authors.lastname: Longano
authors.forename: Suzanne M
authors.initials: SM
authors.lastname: Garland
authors.forename: Melissa C
authors.initials: MC
authors.lastname: Southey
authors.affiliation: Cancer Epidemiology Centre, Cancer Council Victoria, Melbourne, VIC 3004, Australia. Graham.Giles@cancervic.org.au.
authors.forename: Graham G
authors.initials: GG
authors.lastname: Giles
mesh_terms: D004247:DNA / Q000032:analysis; D006801:Humans; D008297:Male; D008875:Middle Aged; D058889:Molecular Typing / Q000379:methods; D045704:Mycoplasma genitalium / Q000235:genetics / Q000302:isolation & purification*; D011471:Prostatic Neoplasms / Q000235:genetics / Q000382:microbiology* / Q000473:pathology*; D012749:Sexually Transmitted Diseases / Q000453:epidemiology / Q000382:microbiology; D018139:Simplexvirus / Q000235:genetics / Q000302:isolation & purification*; D016990:Ureaplasma urealyticum / Q000235:genetics / Q000302:isolation & purification*
chemical_list: D004247:DNA
references.citation: J Clin Microbiol. 1992 Feb;30(2):465-72
references.pmid: 1537918
references.citation: J Natl Cancer Inst. 1994 Apr 6;86(7):494-9
references.pmid: 8133532
references.citation: Carcinogenesis. 2004 Jun;25(6):961-6
references.pmid: 14754878
references.citation: Cancer Epidemiol Biomarkers Prev. 2007 Aug;16(8):1573-80
references.pmid: 17684131
references.citation: Br J Cancer. 2007 Jan 15;96(1):137-9
references.pmid: 17117176
references.citation: J Microbiol Methods. 2005 Jan;60(1):13-9
references.pmid: 15567220
references.citation: PLoS One. 2013;8(2):e54727
references.pmid: 23457453
references.citation: Cancer Epidemiol Biomarkers Prev. 2006 May;15(5):939-45
references.pmid: 16702374
references.citation: Hum Pathol. 1992 Mar;23(3):273-9
references.pmid: 1555838
references.citation: Fam Med. 2005 Jul-Aug;37(7):506-12
references.pmid: 15988645
references.citation: Lancet. 1990 Feb 10;335(8685):357-8
references.pmid: 1967796
references.citation: IARC Sci Publ. 2002;156:69-70
references.pmid: 12484128
references.citation: Carcinogenesis. 2010 Sep;31(9):1597-603
references.pmid: 20576793
references.citation: N Engl J Med. 2007 May 10;356(19):1928-43
references.pmid: 17494926
references.citation: J Clin Microbiol. 2012 Aug;50(8):2796-8
references.pmid: 22649012
references.citation: BMC Cancer. 2010 Jun 24;10:326
references.pmid: 20576103
references.citation: J Natl Cancer Inst. 1990 Sep 19;82(18):1477-84
references.pmid: 2167986
references.citation: J Infect Dis. 2001 Dec 1;184(11):1494-5; author reply 1495-6
references.pmid: 11709797
references.citation: Ann Oncol. 2001 Jun;12(6):761-5
references.pmid: 11484949
references.citation: Proc Natl Acad Sci U S A. 2009 Sep 22;106(38):16351-6
references.pmid: 19805305
references.citation: J Clin Microbiol. 2004 Feb;42(2):683-92
references.pmid: 14766837
references.citation: N Y State J Med. 1951 Jun 15;51(12):1519-20
references.pmid: 14853120
references.citation: Cancer Res. 2005 Dec 15;65(24):11771-8
references.pmid: 16357190
references.citation: Semin Cancer Biol. 1999 Dec;9(6):423-30
references.pmid: 10712889
references.citation: J Infect Dis. 1997 Jul;176(1):289-92
references.pmid: 9207385
references.citation: J Cell Biochem. 2004 Feb 15;91(3):553-71
references.pmid: 14755685